Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus rating of “Hold” by the ten research firms that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $16.8750.

OSCR has been the topic of a number of recent analyst reports. UBS Group reaffirmed a “neutral” rating and issued a $15.00 price objective on shares of Oscar Health in a research note on Wednesday. Barclays set a $18.00 price target on shares of Oscar Health and gave the stock an “equal weight” rating in a report on Monday, January 5th. Wells Fargo & Company reduced their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research note on Thursday, November 13th. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research report on Thursday, January 22nd.

Insiders Place Their Bets

In other news, insider Mario Schlosser sold 23,038 shares of Oscar Health stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total value of $406,620.70. Following the completion of the sale, the insider owned 350,180 shares in the company, valued at $6,180,677. The trade was a 6.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Adam Mcananey sold 1,852 shares of the business’s stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $30,724.68. Following the transaction, the insider owned 179,241 shares in the company, valued at $2,973,608.19. The trade was a 1.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 197,125 shares of company stock worth $3,265,300 in the last quarter. 25.11% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of OSCR. Farther Finance Advisors LLC grew its stake in shares of Oscar Health by 4,420.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after buying an additional 1,282 shares during the period. Jones Financial Companies Lllp boosted its holdings in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio acquired a new stake in Oscar Health in the first quarter valued at approximately $30,000. Atlantic Union Bankshares Corp acquired a new stake in Oscar Health in the second quarter valued at approximately $33,000. Finally, Fifth Third Bancorp increased its holdings in shares of Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after acquiring an additional 1,413 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

Oscar Health Stock Performance

Shares of Oscar Health stock opened at $13.41 on Monday. The stock has a market cap of $3.55 billion, a price-to-earnings ratio of -7.70 and a beta of 1.90. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.80. The company’s fifty day moving average is $15.24 and its 200 day moving average is $16.73. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing the consensus estimate of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 37.72% and a negative net margin of 3.79%.The company had revenue of $2.76 billion for the quarter, compared to analyst estimates of $3.12 billion. During the same period in the previous year, the firm posted ($0.62) earnings per share. The firm’s quarterly revenue was up 17.3% compared to the same quarter last year. Sell-side analysts forecast that Oscar Health will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.